7-193254-G-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_020223.4(FAM20C):c.55G>T(p.Val19Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000166 in 1,466,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020223.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM20C | NM_020223.4 | c.55G>T | p.Val19Leu | missense_variant | 1/10 | ENST00000313766.6 | NP_064608.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM20C | ENST00000313766.6 | c.55G>T | p.Val19Leu | missense_variant | 1/10 | 1 | NM_020223.4 | ENSP00000322323 | P1 | |
ENST00000467050.1 | n.233+694C>A | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000660 AC: 99AN: 149972Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000114 AC: 13AN: 113552Hom.: 0 AF XY: 0.000112 AC XY: 7AN XY: 62326
GnomAD4 exome AF: 0.000109 AC: 144AN: 1316748Hom.: 0 Cov.: 30 AF XY: 0.000111 AC XY: 72AN XY: 650060
GnomAD4 genome AF: 0.000660 AC: 99AN: 150080Hom.: 0 Cov.: 33 AF XY: 0.000628 AC XY: 46AN XY: 73276
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.55G>T (p.V19L) alteration is located in exon 1 (coding exon 1) of the FAM20C gene. This alteration results from a G to T substitution at nucleotide position 55, causing the valine (V) at amino acid position 19 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at